検索結果 - Shallis, Rory

More is less, less is more, or does it really matter? The curious case of impact of azacitidine administration schedules on outcomes in patients with myelodysplastic syndromes 著者: Shallis, Rory M., Zeidan, Amer M.

全文の入手 全文の入手 全文の入手

Emerging agents and regimens for polycythemia vera and essential thrombocythemia 著者: Shallis, Rory M., Podoltsev, Nikolai A.

全文の入手 全文の入手 全文の入手

Epigenetic therapy combinations in acute myeloid leukemia: what are the options? 著者: Bewersdorf, Jan Philipp, Shallis, Rory, Stahl, Maximilian, Zeidan, Amer M.

全文の入手 全文の入手 全文の入手

Tobacco Smoking as a Risk Factor for Increased Antibiotic Prescription 著者: Steinberg, Michael B., Akincigil, Ayse, Kim, Eun Jung, Shallis, Rory, Delnevo, Cristine D.

全文の入手 全文の入手 全文の入手

Are We Moving the Needle for Patients with TP53-Mutated Acute Myeloid Leukemia? 著者: Shallis, Rory M., Bewersdorf, Jan P., Stahl, Maximilian F., Halene, Stephanie, Zeidan, Amer M.

全文の入手 全文の入手 全文の入手

Getting personal with myelodysplastic syndromes: is now the right time? 著者: Chokr, Nora, Pine, Alexander B., Bewersdorf, Jan Philipp, Shallis, Rory M., Stahl, Maximilian, Zeidan, Amer M.

全文の入手 全文の入手 全文の入手

Cost-effectiveness of azacitidine and venetoclax in unfit patients with previously untreated acute myeloid leukemia 著者: Patel, Kishan K., Zeidan, Amer M., Shallis, Rory M., Prebet, Thomas, Podoltsev, Nikolai, Huntington, Scott F.

全文の入手 全文の入手 全文の入手

Isolated trisomy 11 in patients with acute myeloid leukemia – Is the prognosis not as grim as previously thought? 著者: Bewersdorf, Jan Philipp, Shallis, Rory M., Diadamo, Autumn, Gowda, Lohith, Podoltsev, Nikolai A., Siddon, Alexa, Zeidan, Amer M.

全文の入手 全文の入手 全文の入手

Changes in Multiple Myeloma Treatment Patterns during the Early COVID-19 Pandemic Period 著者: Neparidze, Natalia, Wang, Rong, Zeidan, Amer M., Podoltsev, Nikolai, Shallis, Rory M., Ma, Xiaomei, Davidoff, Amy J., Huntington, Scott F.

全文の入手 全文の入手

Cost-effectiveness of liposomal cytarabine/daunorubicin in patients with newly diagnosed acute myeloid leukemia 著者: Bewersdorf, Jan Philipp, Patel, Kishan K., Goshua, George, Shallis, Rory M., Podoltsev, Nikolai A., Huntington, Scott F., Zeidan, Amer M.

全文の入手 全文の入手 全文の入手

Changes in multiple myeloma treatment patterns during the early COVID-19 pandemic period 著者: Neparidze, Natalia, Wang, Rong, Zeidan, Amer M., Podoltsev, Nikolai A., Shallis, Rory M., Ma, Xiaomei, Davidoff, Amy J., Huntington, Scott F.

全文の入手 全文の入手 全文の入手

Contemporary practice patterns of tyrosine kinase inhibitor use among older patients with chronic myeloid leukemia in the United States 著者: Shallis, Rory M., Wang, Rong, Bewersdorf, Jan P., Zeidan, Amer M., Davidoff, Amy J., Huntington, Scott F., Podoltsev, Nikolai A., Ma, Xiaomei

全文の入手 全文の入手 全文の入手

Practice patterns and real-life outcomes for patients with acute promyelocytic leukemia in the United States 著者: Bewersdorf, Jan Philipp, Prozora, Stephanie, Podoltsev, Nikolai A., Shallis, Rory M., Huntington, Scott F., Neparidze, Natalia, Wang, Rong, Zeidan, Amer M., Davidoff, Amy J.

全文の入手 全文の入手 全文の入手

Survival of mantle cell lymphoma in the era of Bruton tyrosine kinase inhibitors: a population-based analysis 著者: Di, Mengyang, Cui, Can, Kothari, Shalin K., Zeidan, Amer M., Podoltsev, Nikolai A., Neparidze, Natalia, Shallis, Rory M., Wang, Rong, Ma, Xiaomei, Huntington, Scott F.

全文の入手 全文の入手 全文の入手

Temporal patterns and predictors of receiving no active therapy among older patients with acute myeloid leukemia in the United States: A population level analysis 著者: Zeidan, Amer M., Podoltsev, Nikolai A., Wang, Xiaoyi, Bewersdorf, Jan Philipp, Shallis, Rory M., Huntington, Scott F., Gore, Steven D., Davidoff, Amy J., Ma, Xiaomei, Wang, Rong

全文の入手 全文の入手 全文の入手

Clinical outcomes of older patients with AML receiving hypomethylating agents: a large population-based study in the United States 著者: Zeidan, Amer M., Wang, Rong, Wang, Xiaoyi, Shallis, Rory M., Podoltsev, Nikolai A., Bewersdorf, Jan P., Huntington, Scott F., Neparidze, Natalia, Giri, Smith, Gore, Steven D., Davidoff, Amy J., Ma, Xiaomei

全文の入手 全文の入手 全文の入手

Azacitidine maintenance after allogeneic hematopoietic cell transplantation for MDS and AML 著者: El Chaer, Firas, Borate, Uma, Duléry, Rémy, Holtan, Shernan G., Law, Arjun Datt, Muffly, Lori, Nassereddine, Samah, Shallis, Rory M., Stringaris, Kate, Taylor, Justin, Devine, Steven M., Mohty, Mohamad, Hourigan, Christopher S.

全文の入手 全文の入手 全文の入手

Patterns of care and clinical outcomes with cytarabine-anthracycline induction chemotherapy for AML patients in the United States 著者: Zeidan, Amer M., Podoltsev, Nikolai A., Wang, Xiaoyi, Zhang, Chi, Bewersdorf, Jan Philipp, Shallis, Rory M., Huntington, Scott F., Neparidze, Natalia, Giri, Smith, Gore, Steven D., Davidoff, Amy J., Ma, Xiaomei, Wang, Rong

全文の入手 全文の入手 全文の入手

Clinical outcomes and characteristics of patients with TP53-mutated acute myeloid leukemia or myelodysplastic syndromes: A single center experience 著者: Bewersdorf, Jan Philipp, Shallis, Rory M., Gowda, Lohith, Wei, Wei, Hager, Karl, Isufi, Iris, Kim, Tae Kon, Pillai, Manoj M., Seropian, Stuart, Podoltsev, Nikolai A., Gore, Steven D., Siddon, Alexa J., Zeidan, Amer M.

全文の入手 全文の入手 全文の入手

Real-world outcomes of adult B-cell acute lymphocytic leukemia patients treated with blinatumomab 著者: Badar, Talha, Szabo, Aniko, Advani, Anjali, Wadleigh, Martha, Arslan, Shukaib, Khan, Muhammad Ali, Aldoss, Ibrahim, Siebenaller, Caitlin, Schultz, Elizabeth, Hefazi, Mehrdad, Shallis, Rory M., Yurkiewicz, Ilana, Podoltsev, Nikolai, Patel, Anand A., Curran, Emily, Balasubramanian, Suresh, Yang, Jay, Mattison, Ryan J., Burkart, Madelyn, Dinner, Shira, Liedtke, Michaela, Litzow, Mark R., Atallah, Ehab

全文の入手 全文の入手 全文の入手